Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
Image forming apparatus with an improved density adjustment unit
Optical angular position detection apparatus and method
Electronic time stamping apparatus for use with an inground transmitter
Methods for predicting cardiac toxicity
Single-electron detection method and apparatus for solid-state intensity image sensors with a charge splitting device
Optoelectronic component and method for producing an optoelectronic component
  Randomly Featured Patents
Apparatus for manufacturing bags
Method of establishing a signal path between at least two apparatuses and an arrangement of at least two apparatuses for realising the method
Food cutter for dishwasher
Method of AC welding using a flux cored electrode
Composite male hose coupler
Cyclopentane derivatives
Process for the production of N-substituted acrylic acid amides
Scanning unit
Optical fiber tool
Combined pen and tire gauge